Was geht denn da ab bei MEDX??? - 500 Beiträge pro Seite
eröffnet am 05.01.01 21:18:25 von
neuester Beitrag 05.01.01 21:42:40 von
neuester Beitrag 05.01.01 21:42:40 von
Beiträge: 2
ID: 324.584
ID: 324.584
Aufrufe heute: 0
Gesamt: 596
Gesamt: 596
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 58 Minuten | 941 | |
| vor 55 Minuten | 884 | |
| gestern 21:55 | 493 | |
| vor 53 Minuten | 411 | |
| 15.05.11, 11:34 | 409 | |
| gestern 13:40 | 390 | |
| heute 00:17 | 310 | |
| gestern 21:33 | 297 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.212,91 | +0,28 | 222 | |||
| 2. | 2. | 152,70 | +12,86 | 167 | |||
| 3. | 3. | 0,1950 | +2,09 | 75 | |||
| 4. | 4. | 2.324,92 | +0,12 | 57 | |||
| 5. | 5. | 0,0313 | +95,63 | 49 | |||
| 6. | 7. | 4,7220 | -0,59 | 46 | |||
| 7. | 8. | 13,590 | -6,34 | 46 | |||
| 8. | 6. | 44,10 | +0,46 | 45 |
Feedback
Kann mir einer mal erklären warum MEDX,und alle anderen Biotechs heute so einen Dämpfer kriegen..da steckt doch keine ad-hoc dahinter,die haben wohl nur Schiss inne Buchse,oder wie seht ihr das heutige Szenario dort...gehts noch weiter runter,oder kriegen die bald mal wieder den Arsch hoch!!???Danke für Eure Meinungen!
die frage sollte wohl eher lauten:was geht ab bei den biotechs?
es wird abgeerntet;hier der beweis:
$IXBT - Biotech (Nasdaq)
Updated as of: Jan 05, 2001 @ 3:32 pm ET
Sym. Company Name Last Change %Chg High Low Vol.
$IXBT Biotech (Nasdaq) 928.05 -94.80 -9.3 1018.27 918.64 0
ABGX Abgenix, Inc 38 1/4 -7 -15.5 45 1/4 35 3/8 4.91M
AMRI Albany Molecular Research, Inc. 45 13/16 -6 1/2 -12.4 52 7/8 45 1/2 371K
ALXN Alexion Pharmaceuticals, Inc. 49 11/16 -9 15/16 -16.7 61 15/16 46 15/16 292K
ALKS Alkermes, Inc. 23 1/16 -3 1/2 -13.2 26 11/16 22 3/4 843K
ALKSP Alkermes, Inc. 94 -31 -24.8 95 94 0
ASTI Allergan Specialty Therapeutics, Inc. 23 -1 11/16 -6.8 24 3/16 22 15/16 29.1K
ALLP Alliance Pharmaceutical Corp. 7 13/16 -0 5/16 -3.8 8 1/4 7 13/16 179K
AMBI AMBI Inc. 1 5/32 -0 1/32 -2.6 1 1/4 1 1/32 88.1K
AMGN Amgen Inc. 57 15/16 -4 3/4 -7.6 62 7/16 57 7/8 11.1M
AMLN Amylin Pharmaceuticals, Inc. 7 5/8 -0 19/32 -7.2 8 7/16 7 1/2 121K
ADRX Andrx Corporation 60 3/4 +0 5/8 +1.0 63 58 1/8 726K
APHT Aphton Corp. 16 9/16 -1 15/16 -10.5 18 1/2 15 3/4 32.9K
ARQL ArQule, Inc. 23 13/16 -1 13/16 -7.1 26 3/8 23 1/16 139K
AIMM AutoImmune Inc. 1 19/32 +0 1/32 +2.0 1 5/8 1 17/32 67.6K
AVIR Aviron 55 -7 7/16 -11.9 62 53 7/8 454K
BTGC Bio-Technology General Corp. 6 23/32 -0 7/32 -3.2 7 1/8 6 11/16 286K
BCHE Biochem Pharma Inc. 31 7/8 +0 1/8 +0.4 32 3/8 31 3/4 1.70M
BCRX BioCryst Pharmaceuticals, Inc. 7 15/64 -0 41/64 -8.1 7 7/8 7 1/16 28.5K
BGEN Biogen, Inc. 52 1/16 -3 1/4 -5.9 54 7/64 50 3/4 3.63M
BTRN BioTransplant, Inc. 8 1/4 -0 11/16 -7.7 8 29/32 8 1/4 52.9K
BBII Boston Biomedica, Inc. 2 3/32 -0 15/32 -18.3 3 2 40.8K
BLSI Boston Life Sciences, Inc. 3 7/8 -0 1/16 -1.6 4 1/16 3 13/16 92.4K
CARN Carrington Laboratories, Inc. 1 3/16 +0 1/32 +2.7 1 15/64 1 3/16 13.1K
CEGE Cell Genesys, Inc. 19 5/8 -2 1/4 -10.3 21 3/4 19 5/8 728K
CLPA Cell Pathways, Inc. 6 3/8 -0 3/8 -5.6 7 15/32 6 1/4 512K
CTIC Cell Therapeutics, Inc. 38 5/8 -7 1/8 -15.6 45 5/8 38 1/2 1.06M
CEPH Cephalon, Inc. 50 1/16 -5 7/8 -10.5 56 49 1/4 1.02M
CERS Cerus Corporation 59 13/16 -12 5/16 -17.1 71 7/8 58 7/16 162K
CBLI Chesapeake Biological Laboratories, Inc. 4 1/2 uchg 0.0 4 1/2 4 1/2 10.5K
CHRX ChiRex Inc. 31 1/8 -0 1/16 -0.2 31 1/4 31 1/16 0
CHIR Chiron Corporation 41 1/4 -2 11/16 -6.1 43 7/8 40 1/4 1.74M
CIMA CIMA LABS INC. 61 1/16 -1 3/16 -1.9 62 1/4 58 3/4 225K
CCHE CliniChem Development, Inc. 11 15/16 -1 1/16 -8.2 11 15/16 11 15/16 0
CGPI CollaGenex Pharmaceuticals, Inc. 4 3/4 -0 5/16 -6.2 5 3/8 4 3/4 39.4K
CLTX Collateral Therapeutics, Inc. 15 7/8 -3 15/16 -19.9 20 1/16 15 3/4 57.2K
CNCT Connetics Corporation 4 3/4 -0 5/16 -6.2 5 1/8 4 9/16 98.4K
CORR COR Therapeutics, Inc. 26 1/4 -2 1/2 -8.7 28 3/4 26 911K
CRXA Corixa Corporation 21 5/8 -3 1/8 -12.6 25 21 1/2 276K
CLTR Coulter Pharmaceutical, Inc. 25 1/8 -5 3/8 -17.6 25 1/8 21 5/8 0
CBST Cubist Pharmaceuticals, Inc. 25 3/4 -1 15/16 -7.0 27 3/4 25 11/16 537K
CYPH Cytoclonal Pharmaceutics Inc. 7 23/32 -0 3/16 -2.4 7 15/16 7 9/16 149K
CYTO Cytogen Corporation 3 1/16 -0 3/16 -5.8 3 1/2 2 15/16 409K
CYTR CytRx Corporation 0 29/32 +0 1/32 +3.6 0 15/16 0 13/16 50.5K
DCRN Diacrin, Inc. 4 3/4 uchg 0.0 4 13/16 4 3/4 2.60K
DURA Dura Pharmaceuticals, Inc. 35 5/16 +1 11/16 +5.0 35 11/16 33 5/8 2.12M
DRMD Duramed Pharmaceuticals, Inc. 4 1/2 -0 5/16 -6.5 5 4 3/8 126K
DUSA DUSA Pharmaceuticals, Inc. 13 3/16 -1 1/4 -8.7 14 1/4 13 57.9K
ENMD EntreMed, Inc. 16 1/2 -0 3/4 -4.3 17 13/16 16 1/8 224K
ENZN Enzon, Inc. 46 3/8 -9 15/16 -17.6 56 5/8 44 1/2 1.54M
EPIX EPIX Medical, Inc. 10 +0 1/2 +5.3 10 5/16 9 9/16 61.9K
ERGO Ergo Science Corporation 0 5/8 -0 1/32 -4.8 0 21/32 0 5/8 4.50K
GGEN GalaGen Inc. 1 1/32 -0 1/32 -2.9 1 1/4 1 1/32 300
GELX GelTex Pharmaceuticals, Inc. 47 1/2 -0 3/16 -0.4 47 13/16 47 1/2 0
GNLB Genelabs Technologies, Inc. 4 7/8 -0 9/16 -10.3 5 1/4 4 17/32 395K
GNTA Genta Incorporated 7 11/16 -0 11/32 -4.3 8 1/4 7 9/16 150K
GENZ Genzyme General 76 1/8 -6 9/16 -7.9 82 11/16 74 2.86M
GZMO Genzyme Molecular Oncology Division 9 1/4 -0 3/8 -3.9 10 1/2 9 1/16 67.1K
GZTR Genzyme Tissue Repair 3 7/8 -1 5/8 -29.5 3 15/16 3 25/32 0
GERN Geron Corporation 14 9/16 -1 5/16 -8.3 16 3/8 14 1/2 312K
GILD Gilead Sciences, Inc. 57 7/8 -7 7/8 -12.0 66 3/16 55 5/8 2.80M
GLIA Gliatech Inc. 6 1/8 +0 1/16 +1.0 6 1/2 6 1/8 48.7K
GLFD Guilford Pharmaceuticals Inc. 16 13/16 -0 1/2 -2.9 17 5/16 16 5/64 61.2K
HSKA Heska Corporation 1 9/32 +0 1/4 +24.2 1 11/32 1 88.7K
HEPH Hollis-Eden Pharmaceuticals, Inc. 5 15/16 -0 1/16 -1.0 6 1/32 5 3/16 21.4K
HGSI Human Genome Sciences, Inc. 54 13/16 -11 15/16 -17.9 66 54 1/2 6.99M
HYSQ Hyseq, Inc. 12 5/16 -1 5/8 -11.7 14 1/16 12 123K
ICOS ICOS Corporation 44 5/8 -5 -10.1 51 11/16 44 5/8 771K
IMCL ImClone Systems Incorporated 30 3/4 -3 1/4 -9.6 34 1/2 30 3/8 1.80M
IMNR Immune Response Corporation (The) 3 3/4 -0 5/16 -7.7 4 1/16 3 1/4 182K
IMNX Immunex Corporation 34 63/64 -5 45/64 -14.0 41 1/16 34 7/8 7.59M
IMGN ImmunoGen, Inc. 18 7/16 -1 13/16 -9.0 20 1/8 18 854K
IMMU Immunomedics, Inc. 16 3/8 -1 11/16 -9.3 19 16 3/16 942K
INCY Incyte Pharmaceuticals, Inc. 19 1/16 -3 45/64 -16.3 22 13/16 19 1.30M
IPIC Interneuron Pharmaceuticals, Inc. 1 7/16 -0 1/16 -4.2 1 17/32 1 7/16 51.8K
IVGN Invitrogen Corporation 61 15/16 -8 3/4 -12.4 70 3/4 59 5/8 1.39M
ISIP Isis Pharmaceuticals, Inc. 9 17/32 -0 21/32 -6.4 10 1/16 9 1/2 131K
KOSP Kos Pharmaceuticals, Inc. 18 1/2 -0 1/4 -1.3 19 18 1/2 73.6K
LJPC LaJolla Pharmaceutical Company 5 -0 1/4 -4.8 5 3/8 4 15/16 35.7K
LGND Ligand Pharmaceuticals Incorporated 12 11/16 -0 7/16 -3.3 13 9/16 12 5/8 194K
LYNX Lynx Therapeutics, Inc. 9 1/16 -0 15/16 -9.4 10 1/8 9 94.0K
MAGN Magainin Pharmaceuticals Inc. 2 1/4 -0 5/32 -6.5 2 15/32 2 1/4 50.5K
MEDI MedImmune, Inc. 42 13/16 -6 7/16 -13.1 49 3/8 42 3/4 2.84M
MRVT Miravant Medical Technologies 6 3/8 -0 15/16 -12.8 7 1/2 6 9/32 141K
NABI NABI 4 63/64 -0 29/64 -8.3 5 1/2 4 3/4 78.2K
NERX NeoRx Corporation 5 3/4 -0 11/16 -10.7 7 7/32 5 11/16 127K
NRGN Neurogen Corporation 29 7/8 -2 5/8 -8.1 31 7/8 29 7/8 22.2K
NPSP NPS Pharmaceuticals, Inc. 31 1/4 -6 3/4 -17.8 38 1/2 30 349K
ONXX ONYX Pharmaceuticals, Inc. 12 7/8 -0 3/16 -1.4 13 11/16 12 5/8 92.6K
OSIP OSI Pharmaceuticals Inc. 64 1/4 +1 3/4 +2.8 66 1/4 61 876K
OXGN OXiGENE, Inc. 5 13/16 -0 1/4 -4.1 5 13/16 5 3/4 3.40K
PGNS PathoGenesis Corporation 38 5/8 -0 5/32 -0.4 38 13/16 38 1/2 30.3K
PCYC Pharmacyclics, Inc. 30 3/4 +2 13/64 +7.7 32 3/4 29 1/8 298K
PGNX Progenics Pharmaceuticals Inc. 17 1/8 -0 3/4 -4.2 20 3/4 17 58.0K
PDLI Protein Design Labs, Inc. 57 1/2 -16 1/2 -22.3 75 1/8 56 3/8 3.87M
REGN Regeneron Pharmaceuticals, Inc. 31 -1 7/16 -4.4 32 3/16 30 3/8 225K
RGEN Repligen Corporation 3 5/8 -0 3/8 -9.4 3 7/8 3 1/2 24.4K
SCLN SciClone Pharmaceuticals, Inc. 5 9/32 -0 9/32 -5.1 5 7/8 5 3/16 181K
SCIO Scios, Inc. 19 11/16 +0 3/4 +4.0 19 7/8 18 1/8 555K
SERO Serologicals Corporation 12 3/4 -0 3/4 -5.6 13 47/64 12 5/8 203K
SHPGY Shire Pharmaceuticals Group, plc 48 +1 3/16 +2.5 49 1/8 47 5/8 690K
SNUS SONUS Pharmaceuticals, Inc. 0 9/16 -0 1/64 -2.7 0 19/32 0 9/16 3.60K
SUPG SuperGen, Inc. 12 3/16 -0 3/4 -5.8 13 1/4 12 1/8 230K
SNAP Synaptic Pharmaceutical Corporation 5 7/16 -0 1/16 -1.1 5 7/16 5 1/4 12.7K
TGEN Targeted Genetics Corporation 8 5/16 +0 9/16 +7.3 8 1/2 7 29/32 258K
TECH Techne Corporation 25 15/16 -1 11/16 -6.1 27 5/8 25 3/4 1.08M
TRGNY TRANSGENE S.A. 8 +0 1/4 +3.2 8 1/4 8 5.10K
TKTX Transkaryotic Therapies, Inc. 30 3/32 -3 5/32 -9.5 33 1/4 28 5/8 119K
VIRS Triangle Pharmaceuticals, Inc. 5 -0 1/2 -9.1 5 1/2 4 29/32 64.8K
TRMS Trimeris, Inc. 47 9/16 -2 9/16 -5.1 49 13/16 47 1/4 190K
TRIBY Trinity Biotech PLC 2 27/32 +0 3/32 +3.4 2 7/8 2 3/4 99.9K
TWLB Twinlab Corporation 1 11/16 -0 1/8 -6.9 1 13/16 1 7/16 34.4K
VITX V. I. Technologies, Inc. 5 7/8 -0 1/4 -4.1 6 5 3/4 25.5K
VRTX Vertex Pharmaceuticals Incorporated 52 3/8 -7 1/2 -12.5 60 3/4 52 3/8 1.78M
VICL Vical Incorporated 15 15/16 -1 3/16 -6.9 17 3/8 15 7/8 104K
VPHM ViroPharma IncorporatedVYSI 14 11/16 -1 3/8 -8.6 16 15/64 14 3/8 97.5K
VYSI Vysis, Inc. 8 3/4 -0 1/8 -1.4 8 7/8 8 1/2 5.20K
XOMA XOMA Ltd 8 11/16 -0 9/16 -6.1 9 5/16 8 9/16 225K
ZMTX ZYMETX, Inc. 1 3/4 +0 3/16 +12.0 1 3/4 1 17/32 3.30K
Updated as of: Jan 05, 2001 @ 3:32 pm ET
mfg rudra
es wird abgeerntet;hier der beweis:
$IXBT - Biotech (Nasdaq)
Updated as of: Jan 05, 2001 @ 3:32 pm ET
Sym. Company Name Last Change %Chg High Low Vol.
$IXBT Biotech (Nasdaq) 928.05 -94.80 -9.3 1018.27 918.64 0
ABGX Abgenix, Inc 38 1/4 -7 -15.5 45 1/4 35 3/8 4.91M
AMRI Albany Molecular Research, Inc. 45 13/16 -6 1/2 -12.4 52 7/8 45 1/2 371K
ALXN Alexion Pharmaceuticals, Inc. 49 11/16 -9 15/16 -16.7 61 15/16 46 15/16 292K
ALKS Alkermes, Inc. 23 1/16 -3 1/2 -13.2 26 11/16 22 3/4 843K
ALKSP Alkermes, Inc. 94 -31 -24.8 95 94 0
ASTI Allergan Specialty Therapeutics, Inc. 23 -1 11/16 -6.8 24 3/16 22 15/16 29.1K
ALLP Alliance Pharmaceutical Corp. 7 13/16 -0 5/16 -3.8 8 1/4 7 13/16 179K
AMBI AMBI Inc. 1 5/32 -0 1/32 -2.6 1 1/4 1 1/32 88.1K
AMGN Amgen Inc. 57 15/16 -4 3/4 -7.6 62 7/16 57 7/8 11.1M
AMLN Amylin Pharmaceuticals, Inc. 7 5/8 -0 19/32 -7.2 8 7/16 7 1/2 121K
ADRX Andrx Corporation 60 3/4 +0 5/8 +1.0 63 58 1/8 726K
APHT Aphton Corp. 16 9/16 -1 15/16 -10.5 18 1/2 15 3/4 32.9K
ARQL ArQule, Inc. 23 13/16 -1 13/16 -7.1 26 3/8 23 1/16 139K
AIMM AutoImmune Inc. 1 19/32 +0 1/32 +2.0 1 5/8 1 17/32 67.6K
AVIR Aviron 55 -7 7/16 -11.9 62 53 7/8 454K
BTGC Bio-Technology General Corp. 6 23/32 -0 7/32 -3.2 7 1/8 6 11/16 286K
BCHE Biochem Pharma Inc. 31 7/8 +0 1/8 +0.4 32 3/8 31 3/4 1.70M
BCRX BioCryst Pharmaceuticals, Inc. 7 15/64 -0 41/64 -8.1 7 7/8 7 1/16 28.5K
BGEN Biogen, Inc. 52 1/16 -3 1/4 -5.9 54 7/64 50 3/4 3.63M
BTRN BioTransplant, Inc. 8 1/4 -0 11/16 -7.7 8 29/32 8 1/4 52.9K
BBII Boston Biomedica, Inc. 2 3/32 -0 15/32 -18.3 3 2 40.8K
BLSI Boston Life Sciences, Inc. 3 7/8 -0 1/16 -1.6 4 1/16 3 13/16 92.4K
CARN Carrington Laboratories, Inc. 1 3/16 +0 1/32 +2.7 1 15/64 1 3/16 13.1K
CEGE Cell Genesys, Inc. 19 5/8 -2 1/4 -10.3 21 3/4 19 5/8 728K
CLPA Cell Pathways, Inc. 6 3/8 -0 3/8 -5.6 7 15/32 6 1/4 512K
CTIC Cell Therapeutics, Inc. 38 5/8 -7 1/8 -15.6 45 5/8 38 1/2 1.06M
CEPH Cephalon, Inc. 50 1/16 -5 7/8 -10.5 56 49 1/4 1.02M
CERS Cerus Corporation 59 13/16 -12 5/16 -17.1 71 7/8 58 7/16 162K
CBLI Chesapeake Biological Laboratories, Inc. 4 1/2 uchg 0.0 4 1/2 4 1/2 10.5K
CHRX ChiRex Inc. 31 1/8 -0 1/16 -0.2 31 1/4 31 1/16 0
CHIR Chiron Corporation 41 1/4 -2 11/16 -6.1 43 7/8 40 1/4 1.74M
CIMA CIMA LABS INC. 61 1/16 -1 3/16 -1.9 62 1/4 58 3/4 225K
CCHE CliniChem Development, Inc. 11 15/16 -1 1/16 -8.2 11 15/16 11 15/16 0
CGPI CollaGenex Pharmaceuticals, Inc. 4 3/4 -0 5/16 -6.2 5 3/8 4 3/4 39.4K
CLTX Collateral Therapeutics, Inc. 15 7/8 -3 15/16 -19.9 20 1/16 15 3/4 57.2K
CNCT Connetics Corporation 4 3/4 -0 5/16 -6.2 5 1/8 4 9/16 98.4K
CORR COR Therapeutics, Inc. 26 1/4 -2 1/2 -8.7 28 3/4 26 911K
CRXA Corixa Corporation 21 5/8 -3 1/8 -12.6 25 21 1/2 276K
CLTR Coulter Pharmaceutical, Inc. 25 1/8 -5 3/8 -17.6 25 1/8 21 5/8 0
CBST Cubist Pharmaceuticals, Inc. 25 3/4 -1 15/16 -7.0 27 3/4 25 11/16 537K
CYPH Cytoclonal Pharmaceutics Inc. 7 23/32 -0 3/16 -2.4 7 15/16 7 9/16 149K
CYTO Cytogen Corporation 3 1/16 -0 3/16 -5.8 3 1/2 2 15/16 409K
CYTR CytRx Corporation 0 29/32 +0 1/32 +3.6 0 15/16 0 13/16 50.5K
DCRN Diacrin, Inc. 4 3/4 uchg 0.0 4 13/16 4 3/4 2.60K
DURA Dura Pharmaceuticals, Inc. 35 5/16 +1 11/16 +5.0 35 11/16 33 5/8 2.12M
DRMD Duramed Pharmaceuticals, Inc. 4 1/2 -0 5/16 -6.5 5 4 3/8 126K
DUSA DUSA Pharmaceuticals, Inc. 13 3/16 -1 1/4 -8.7 14 1/4 13 57.9K
ENMD EntreMed, Inc. 16 1/2 -0 3/4 -4.3 17 13/16 16 1/8 224K
ENZN Enzon, Inc. 46 3/8 -9 15/16 -17.6 56 5/8 44 1/2 1.54M
EPIX EPIX Medical, Inc. 10 +0 1/2 +5.3 10 5/16 9 9/16 61.9K
ERGO Ergo Science Corporation 0 5/8 -0 1/32 -4.8 0 21/32 0 5/8 4.50K
GGEN GalaGen Inc. 1 1/32 -0 1/32 -2.9 1 1/4 1 1/32 300
GELX GelTex Pharmaceuticals, Inc. 47 1/2 -0 3/16 -0.4 47 13/16 47 1/2 0
GNLB Genelabs Technologies, Inc. 4 7/8 -0 9/16 -10.3 5 1/4 4 17/32 395K
GNTA Genta Incorporated 7 11/16 -0 11/32 -4.3 8 1/4 7 9/16 150K
GENZ Genzyme General 76 1/8 -6 9/16 -7.9 82 11/16 74 2.86M
GZMO Genzyme Molecular Oncology Division 9 1/4 -0 3/8 -3.9 10 1/2 9 1/16 67.1K
GZTR Genzyme Tissue Repair 3 7/8 -1 5/8 -29.5 3 15/16 3 25/32 0
GERN Geron Corporation 14 9/16 -1 5/16 -8.3 16 3/8 14 1/2 312K
GILD Gilead Sciences, Inc. 57 7/8 -7 7/8 -12.0 66 3/16 55 5/8 2.80M
GLIA Gliatech Inc. 6 1/8 +0 1/16 +1.0 6 1/2 6 1/8 48.7K
GLFD Guilford Pharmaceuticals Inc. 16 13/16 -0 1/2 -2.9 17 5/16 16 5/64 61.2K
HSKA Heska Corporation 1 9/32 +0 1/4 +24.2 1 11/32 1 88.7K
HEPH Hollis-Eden Pharmaceuticals, Inc. 5 15/16 -0 1/16 -1.0 6 1/32 5 3/16 21.4K
HGSI Human Genome Sciences, Inc. 54 13/16 -11 15/16 -17.9 66 54 1/2 6.99M
HYSQ Hyseq, Inc. 12 5/16 -1 5/8 -11.7 14 1/16 12 123K
ICOS ICOS Corporation 44 5/8 -5 -10.1 51 11/16 44 5/8 771K
IMCL ImClone Systems Incorporated 30 3/4 -3 1/4 -9.6 34 1/2 30 3/8 1.80M
IMNR Immune Response Corporation (The) 3 3/4 -0 5/16 -7.7 4 1/16 3 1/4 182K
IMNX Immunex Corporation 34 63/64 -5 45/64 -14.0 41 1/16 34 7/8 7.59M
IMGN ImmunoGen, Inc. 18 7/16 -1 13/16 -9.0 20 1/8 18 854K
IMMU Immunomedics, Inc. 16 3/8 -1 11/16 -9.3 19 16 3/16 942K
INCY Incyte Pharmaceuticals, Inc. 19 1/16 -3 45/64 -16.3 22 13/16 19 1.30M
IPIC Interneuron Pharmaceuticals, Inc. 1 7/16 -0 1/16 -4.2 1 17/32 1 7/16 51.8K
IVGN Invitrogen Corporation 61 15/16 -8 3/4 -12.4 70 3/4 59 5/8 1.39M
ISIP Isis Pharmaceuticals, Inc. 9 17/32 -0 21/32 -6.4 10 1/16 9 1/2 131K
KOSP Kos Pharmaceuticals, Inc. 18 1/2 -0 1/4 -1.3 19 18 1/2 73.6K
LJPC LaJolla Pharmaceutical Company 5 -0 1/4 -4.8 5 3/8 4 15/16 35.7K
LGND Ligand Pharmaceuticals Incorporated 12 11/16 -0 7/16 -3.3 13 9/16 12 5/8 194K
LYNX Lynx Therapeutics, Inc. 9 1/16 -0 15/16 -9.4 10 1/8 9 94.0K
MAGN Magainin Pharmaceuticals Inc. 2 1/4 -0 5/32 -6.5 2 15/32 2 1/4 50.5K
MEDI MedImmune, Inc. 42 13/16 -6 7/16 -13.1 49 3/8 42 3/4 2.84M
MRVT Miravant Medical Technologies 6 3/8 -0 15/16 -12.8 7 1/2 6 9/32 141K
NABI NABI 4 63/64 -0 29/64 -8.3 5 1/2 4 3/4 78.2K
NERX NeoRx Corporation 5 3/4 -0 11/16 -10.7 7 7/32 5 11/16 127K
NRGN Neurogen Corporation 29 7/8 -2 5/8 -8.1 31 7/8 29 7/8 22.2K
NPSP NPS Pharmaceuticals, Inc. 31 1/4 -6 3/4 -17.8 38 1/2 30 349K
ONXX ONYX Pharmaceuticals, Inc. 12 7/8 -0 3/16 -1.4 13 11/16 12 5/8 92.6K
OSIP OSI Pharmaceuticals Inc. 64 1/4 +1 3/4 +2.8 66 1/4 61 876K
OXGN OXiGENE, Inc. 5 13/16 -0 1/4 -4.1 5 13/16 5 3/4 3.40K
PGNS PathoGenesis Corporation 38 5/8 -0 5/32 -0.4 38 13/16 38 1/2 30.3K
PCYC Pharmacyclics, Inc. 30 3/4 +2 13/64 +7.7 32 3/4 29 1/8 298K
PGNX Progenics Pharmaceuticals Inc. 17 1/8 -0 3/4 -4.2 20 3/4 17 58.0K
PDLI Protein Design Labs, Inc. 57 1/2 -16 1/2 -22.3 75 1/8 56 3/8 3.87M
REGN Regeneron Pharmaceuticals, Inc. 31 -1 7/16 -4.4 32 3/16 30 3/8 225K
RGEN Repligen Corporation 3 5/8 -0 3/8 -9.4 3 7/8 3 1/2 24.4K
SCLN SciClone Pharmaceuticals, Inc. 5 9/32 -0 9/32 -5.1 5 7/8 5 3/16 181K
SCIO Scios, Inc. 19 11/16 +0 3/4 +4.0 19 7/8 18 1/8 555K
SERO Serologicals Corporation 12 3/4 -0 3/4 -5.6 13 47/64 12 5/8 203K
SHPGY Shire Pharmaceuticals Group, plc 48 +1 3/16 +2.5 49 1/8 47 5/8 690K
SNUS SONUS Pharmaceuticals, Inc. 0 9/16 -0 1/64 -2.7 0 19/32 0 9/16 3.60K
SUPG SuperGen, Inc. 12 3/16 -0 3/4 -5.8 13 1/4 12 1/8 230K
SNAP Synaptic Pharmaceutical Corporation 5 7/16 -0 1/16 -1.1 5 7/16 5 1/4 12.7K
TGEN Targeted Genetics Corporation 8 5/16 +0 9/16 +7.3 8 1/2 7 29/32 258K
TECH Techne Corporation 25 15/16 -1 11/16 -6.1 27 5/8 25 3/4 1.08M
TRGNY TRANSGENE S.A. 8 +0 1/4 +3.2 8 1/4 8 5.10K
TKTX Transkaryotic Therapies, Inc. 30 3/32 -3 5/32 -9.5 33 1/4 28 5/8 119K
VIRS Triangle Pharmaceuticals, Inc. 5 -0 1/2 -9.1 5 1/2 4 29/32 64.8K
TRMS Trimeris, Inc. 47 9/16 -2 9/16 -5.1 49 13/16 47 1/4 190K
TRIBY Trinity Biotech PLC 2 27/32 +0 3/32 +3.4 2 7/8 2 3/4 99.9K
TWLB Twinlab Corporation 1 11/16 -0 1/8 -6.9 1 13/16 1 7/16 34.4K
VITX V. I. Technologies, Inc. 5 7/8 -0 1/4 -4.1 6 5 3/4 25.5K
VRTX Vertex Pharmaceuticals Incorporated 52 3/8 -7 1/2 -12.5 60 3/4 52 3/8 1.78M
VICL Vical Incorporated 15 15/16 -1 3/16 -6.9 17 3/8 15 7/8 104K
VPHM ViroPharma IncorporatedVYSI 14 11/16 -1 3/8 -8.6 16 15/64 14 3/8 97.5K
VYSI Vysis, Inc. 8 3/4 -0 1/8 -1.4 8 7/8 8 1/2 5.20K
XOMA XOMA Ltd 8 11/16 -0 9/16 -6.1 9 5/16 8 9/16 225K
ZMTX ZYMETX, Inc. 1 3/4 +0 3/16 +12.0 1 3/4 1 17/32 3.30K
Updated as of: Jan 05, 2001 @ 3:32 pm ET
mfg rudra
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 222 | ||
| 167 | ||
| 75 | ||
| 57 | ||
| 49 | ||
| 46 | ||
| 46 | ||
| 45 | ||
| 34 | ||
| 31 |
| Wertpapier | Beiträge | |
|---|---|---|
| 29 | ||
| 25 | ||
| 23 | ||
| 21 | ||
| 19 | ||
| 19 | ||
| 19 | ||
| 18 | ||
| 18 | ||
| 18 |
